Latest

Zhanyan Biotech Sprinting Toward the Beijing Stock Exchange: After Shedding Its Medical Aesthetics Business, Still Struggling to Shake Off the "Medical Aesthetics Mask" Label

Zhanyan Biotech Sprinting Toward the Beijing Stock Exchange: After Shedding Its Medical Aesthetics Business, Still Struggling to Shake Off the "Medical Aesthetics Mask" Label

June 29, the listing application of Zhanyan Biotechnology Co., Ltd. (hereinafter referred to as "Zhanyan Bio") on the Beijing Stock Exchange was accepted. This company mainly focuses on dermatology-grade skincare and medical device skin repair products, and owns brands such as “Zhanyan”, “Zhan Xiaoyan”, and “Defillin”. In 2025,
Admin
Cambrian: If upstream raw material prices continue to rise in the future, it may have an adverse impact on the company's operating performance.

Cambrian: If upstream raw material prices continue to rise in the future, it may have an adverse impact on the company's operating performance.

``` Cambrian Stock Trading Risk Warning Announcement: The company operates under a Fabless model, and its suppliers include IP licensing providers, server manufacturers, wafer fabrication plants, and packaging and testing companies. As the entire integrated circuit industry chain is specialized and has a high technical threshold, and some subsidiaries have been
Admin